Download PDF
Synlett 2024; 35(20): 2559-2663
DOI: 10.1055/a-2373-0372
letter
Special Issue to Celebrate the 75th Birthday of Prof. B. C. Ranu

Studies toward the Synthesis of Colletotrichamide A: Construction of the C19–C30 Segment of the Molecule

Nemilikonda Sravan Kumar
a   Department of Organic Synthesis and Process Chemistry, CSIR - Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500 007, India
,
Radhakrishna Gattu
a   Department of Organic Synthesis and Process Chemistry, CSIR - Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500 007, India
,
B. Janaki Ramulu
a   Department of Organic Synthesis and Process Chemistry, CSIR - Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500 007, India
,
Subhash Ghosh 
a   Department of Organic Synthesis and Process Chemistry, CSIR - Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500 007, India
b   Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India
› Author AffiliationsWe are grateful to the Science and Engineering Research Board, Department of Science and Technology, India for funding this project (grant no. CRG/2022/001820) and to the UGC and CSIR for fellowships to N.S.K and R.K.G., respectively.
› Further Information
    Permissions and Reprints All articles of this category


Abstract

A synthesis of the C19–C30 segment of the neuroprotective natural product colletotrichamide A has been achieved by performing a Sonogashira coupling of two advanced intermediate fragments: a vinyl iodide and an alkyne. A Maruoka–Keck allylation, an Evans syn-aldol reaction, and Takai olefinations served as the key steps in the synthesis of the vinyl iodide intermediate, whereas glycosidation and Ohira–Bestmann reactions were used as the pivotal steps for accessing the advanced alkyne intermediate.

Key words:

colletotrichamide A - neurodegenerative disease - Maruoka–Keck allylation - Evans syn-aldol reaction - glycosidation - Sonogashira reaction

Supporting Information

    Supporting information for this article is available online at https://doi.org/10.1055/a-2373-0372.
  • Supporting Information


Publication History

Received: 14 June 2024

Accepted after revision: 23 July 2024

Accepted Manuscript online:
25 July 2024

Article published online:
22 August 2024

© 2024. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References and Notes

  • 1 Heemels M.-T. Nature 2016; 539: 179
    CrossrefPubMed
  • 2 GBD 2015 Neurological Disorders Collaborator Group 2017; 16: 877
  • 3 Kumar A, Singh AA, Ekavali Ekavali. Pharmacol. Rep. 2015; 67: 195
    CrossrefPubMed
  • 4 Bang S, Lee C, Kim S, Song HJ, Kang SK, Deyrup ST, Nam J.-S, Xia X, Shim HS. J. Org. Chem. 2019; 84: 10999
    CrossrefPubMed
    • 5a Chen J, Jian Y, Yan J, Xu C, Ye T. Molecules 2023; 28: 7194
      CrossrefPubMed
    • 5b Fujii K, Ikai Y, Oka H, Suzuki M, Hrada K. Anal. Chem. 1997; 69: 5146
      Crossref
    • 6a Hanawa H, Hashimoto T, Maruoka K. J. Am. Chem. Soc. 2003; 125: 1708
      CrossrefPubMed
    • 6b Yadav JS, Suresh B, Srihari P. Eur. J. Org. Chem. 2015; 5856
      Crossref
    • 6c de Fátima Â, Kohn LK, Antônio MA, de Carvalho JE, Pilli RA. Bioorg. Med. Chem. 2005; 13: 2927
      CrossrefPubMed
  • 7 Yadav JS, Dhara S, Mohapatra DK. Tetrahedron 2017; 73: 1358
    Crossref
  • 8 Cachoux F, Isarno T, Wartmann M, Altmann K.-H. Angew. Chem. Int. Ed. 2005; 44: 7469
    CrossrefPubMed
  • 9 Davies JA, Bull FM, Walker PD, Weir AN. M, Lavigne R, Masschelein J, Simpson TJ, Race PR, Crump MP, Willis CL. Org. Lett. 2020; 22: 6349
    CrossrefPubMed
  • 10 Wang G, Yin N, Negishi E.-i. Chem. Eur. J. 2011; 17: 4118
    CrossrefPubMed
  • 11 Evans DA, Bartroli J, Shih TL. J. Am. Chem. Soc. 1981; 103: 2127
    Crossref
    • 12a Evans DA, Ennis MD, Mathre DJ. J. Am. Chem. Soc. 1982; 104: 1737
      CrossrefPubMed
    • 12b Evans DA, Trenkle WC, Zhang J, Burch JD. Org. Lett. 2005; 7: 3335
      CrossrefPubMed
  • 13 Lafontaine JA, Provencal DP, Gardelli C, Leahy JW. J. Org. Chem. 2003; 68: 4215
    CrossrefPubMed
  • 14 Peng Z.-H, Woerpel KA. J. Am. Chem. Soc. 2003; 125: 6018
    CrossrefPubMed
  • 15 Ramachandran PV, Srivastava A, Hazra D. Org. Lett. 2007; 9: 157
    CrossrefPubMed
    • 16a Takai K, Nitta K, Utimoto K. J. Am. Chem. Soc. 1986; 108: 7408
      Crossref
    • 16b Ghosh AK, Kassekert LA, Bungard JD. Org. Biomol. Chem. 2016; 14: 11357
      CrossrefPubMed
  • 17 Loscher S, Schobert R. Chem. Eur. J. 2013; 19: 10619
    CrossrefPubMed
    • 18a Lawandi J, Rocheleau S, Moitessier NJ. Tetrahedron 2011; 67: 8411
      Crossref
    • 18b Yang S, Liu Q, Zhang G, Zhang X, Zhao Z, Lei P. J. Org. Chem. 2018; 83: 5897
      CrossrefPubMed
  • 20 Shepard MS, Carreira EM. J. Am. Chem. Soc. 1997; 119: 2597
    Crossref
  • 21 Borowski D, Oechsner RM, Jürgens E, Ziegler T. Eur. J. Org. Chem. 2017; 4490
    Crossref
  • 22 Itoh K, Huang Z, Liu H.-w. Org. Lett. 2007; 9: 879
    CrossrefPubMed
  • 23 Ryu J.-H, Lee E, Lim Y.-b, Lee M. J. Am. Chem. Soc. 2007; 129: 4808
    CrossrefPubMed
    • 24a El Sous M, Ganame D, Tregloan PA. Rizzacasa M. A. Org. Lett. 2004; 6: 3001
      CrossrefPubMed
    • 24b Olpp T, Brückner R. Angew. Chem. Int. Ed. 2006; 45: 4023
      CrossrefPubMed
    • 25a Sonogashira K, Tohda Y, Hagihara N. Tetrahedron Lett. 1975; 16: 4467
      CrossrefPubMed
    • 25b Zhou J, Gao B, Xu Z, Ye T. J. Am. Chem. Soc. 2016; 138: 6948
      CrossrefPubMed
  • 26 (5R,6S)-5-[(2S,3S,4E,8R)-2-[(4-Methoxybenzyl)oxy]-3-meth­yl-8-({(2R,3S,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-[(benzyloxy)methyl]tetrahydro-2H-pyran-2-yl}oxy)non-4-en-6-yn-1-yl]-2,2,3,3,6,10,10-heptamethyl-9,9-diphenyl-4,8-dioxa-3,9-disilaundecane (28) Pd(PPh3)4 (231 mg, 0.20 mmol) and CuI (152 mg, 0.80 mmol) were added to a solution of vinyl iodide 9 (300 mg, 0.40 mmol), alkyne 10 (271 mg, 0.46 mmol), and Et3N (86 μL, 0.60 mmol) in anhyd THF (10 mL) under argon at rt, and the mixture was stirred at rt for 5 h. The reaction was then quenched with sat. aq of NH4Cl (15 mL) and the mixture was extracted with EtOAc (3 × 20 mL). The combined organic extracts were washed with brine (10 mL), dried (Na2SO4), and concentrated in vacuo. The residue was purified by gel column chromatography [silica gel (100–200 mesh), 10% EtOAc–hexane] to give a white solid; yield: 415 mg (87%); Rf = 0.5 (silica gel, 20% EtOAc–hexane); [α]D 25 –5.9 (c 1.2, CHCl3). IR (neat): 3065, 3031, 2955, 2928, 1612, 1587, 1513, 1438, 1249, 1105, 1066, 824, 738 cm–1. 1H NMR (400 MHz, CDCl3): δ = 7.72–7.68 (m, 1 H), 7.65–7.60 (m, 4 H), 7.56–7.50 (m, 1 H), 7.49–7.45 (m, 2 H), 7.42–7.31 (m, 9 H), 7.29–7.25 (m, 10 H), 7.24–7.22 (m, 2 H), 7.21–7.17 (m, 3 H), 6.86–6.80 (m, 2 H), 6.20 (dd, J = 16.0, 7.1 Hz, 1 H), 5.47 (d, J = 16.0 Hz, 1 H), 4.99 (d, J = 12.4 Hz, 1 H), 4.88 (q, J = 7.7 Hz, 2 H), 4.72 (q, J = 6.3 Hz, 1 H), 4.67–4.43 (m, 6 H), 4.38 (s, 2 H), 4.22 (t, J = 6.1 Hz, 1 H), 3.93–3.84 (m, 2 H), 3.80–3.77 (m, 2 H), 3.75 (s, 3 H), 3.61 (dd, J = 10.0, 7.5 Hz, 1 H), 3.53 (dd, J = 9.3, 2.7 Hz, 1 H), 3.50–3.40 (m, 3 H), 2.48 (t, J = 7.7 Hz, 1 H), 2.34 (t, J = 7.5 Hz, 1 H), 1.95–1.89 (m, 1 H), 1.70–1.67 (m, 1 H), 1.49 (d, J = 6.6 Hz, 3 H), 1.04 (s, 9 H), 0.93 (dd, J = 6.7, 2.2 Hz, 3 H), 0.88 (d, J = 6.4 Hz, 3 H), 0.83 (s, 9 H), 0.00 (s, 3 H), –0.02 (s, 3 H). 13C NMR (100 MHz, CDCl3): δ = 159.1, 147.8, 138.9, 138.6, 138.5, 138.3, 135.6, 135.4, 135.3, 135.2, 133.9, 133.8, 131.8, 131.0, 130.3, 129.7, 129.3, 128.5, 128.4, 128.4, 128.3, 128.2, 128.1, 128.0, 127.7, 127.6, 127.4, 127.3, 113.8, 108.9, 99.0, 87.7, 84.2, 82.6, 78.8, 76.2, 75.2, 74.9, 74.1, 74.0, 73.6, 71.5, 71.3, 70.5, 69.7, 66.0, 65.1, 55.3, 41.1, 39.6, 34.0, 27.0, 26.0, 22.3, 19.3, 18.1, 13.6, 12.3, –4.0, –4.2. MS (ESI): m/z = 1268 [M + NH4]+. HRMS (ESI): m/z [M + NH4]+ calcd for : 1268.7042; found: 1268.7081